Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Centre for Vaccinology, University of Geneva, Geneva, Switzerland.
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.02127-19.
Childhood immunization with the live-attenuated varicella-zoster virus (VZV) vaccine induces protective immune responses. Routine VZV vaccination started only 2 decades ago, and thus, there are few studies examining the longevity of vaccine-induced immunity. Here, we analyzed the quantity of VZV-specific plasma cells (PCs) and CD4 T cells in the bone marrow (BM) of healthy young adults ( = 15) following childhood VZV immunization. Long-lived BM resident plasma cells constitutively secrete antibodies, and we detected VZV-specific PCs in the BM of all subjects. Anti-VZV plasma antibody titers correlated positively with the number of VZV-specific BM PCs. Furthermore, we quantified the number of interferon gamma (IFN-γ)-producing CD4 T cells specific for VZV glycoprotein E and all other structural and nonstructural VZV proteins in both BM and blood (peripheral blood mononuclear cells [PBMCs]). The frequency of VZV-specific IFN-γ-producing CD4 T cells was significantly higher in PBMCs than BM. Our study shows that VZV-specific PCs and VZV-specific CD4 memory T cells persist up to 20 years after vaccination. These findings indicate that childhood VZV vaccination can elicit long-lived immune memory responses in the bone marrow. Childhood varicella-zoster virus (VZV) immunization induces immune memory responses that protect against primary VZV infection, chicken pox. In the United States, routine childhood VZV vaccination was introduced only 2 decades ago. Hence, there is limited information on the longevity of B and CD4 T cell memory, which are both important for protection. Here, we showed in 15 healthy young adults that VZV-specific B and CD4 T cell responses are detectable in bone marrow (BM) and blood up to 20 years after vaccination. Specifically, we measured antibody-secreting plasma cells in the BM and VZV-specific CD4 T cells in BM and blood. These findings suggest that childhood VZV vaccination induces long-lived immunity.
儿童期接种减毒活水痘带状疱疹病毒(VZV)疫苗可诱导保护性免疫应答。常规 VZV 疫苗接种仅在 20 年前开始,因此,很少有研究检查疫苗诱导免疫的持久性。在这里,我们分析了 15 名健康年轻成年人(= 15)在儿童期 VZV 免疫接种后骨髓(BM)中 VZV 特异性浆细胞(PC)和 CD4 T 细胞的数量。长寿 BM 驻留浆细胞持续分泌抗体,我们在所有受试者的 BM 中检测到 VZV 特异性 PC。抗 VZV 血浆抗体滴度与 VZV 特异性 BM PC 的数量呈正相关。此外,我们定量测定了 BM 和血液(外周血单核细胞[PBMC])中针对 VZV 糖蛋白 E 以及所有其他结构和非结构 VZV 蛋白的干扰素γ(IFN-γ)产生的 CD4 T 细胞的数量。VZV 特异性 IFN-γ产生的 CD4 T 细胞在 PBMC 中的频率明显高于 BM。我们的研究表明,VZV 特异性 PC 和 VZV 特异性 CD4 记忆 T 细胞在接种疫苗后可持续长达 20 年。这些发现表明,儿童期 VZV 疫苗接种可在骨髓中引发长期的免疫记忆反应。